Study reveals motivation behind ‘sunbed’ use
by Gary Finnegan – World Health Matters (Germany) – Millions of people in Europe, the US and elsewhere use tanning beds every year ignoring the risk of skin… read more.
by Gary Finnegan – World Health Matters (Germany) – Millions of people in Europe, the US and elsewhere use tanning beds every year ignoring the risk of skin… read more.
by Marybeth Burke – Regorafenib significantly improved progression-free survival (PFS) and disease control rate (DCR) in patients with advanced gastrointestinal stromal tumours (GIST) that progress due to resistance… read more.
by Marybeth Burke – The investigational agent trastuzumab emtansine (T-DM1) demonstrated improved efficacy over capecitibine plus lapatinib and improved progression-free survival (PFS) in women with HER2-positive locally advanced… read more.
by Marybeth Burke – Continuous hormonal therapy is more effective than intermittent hormonal therapy for men with hormone-sensitive metastatic prostate cancer with minimal disease spread,
25 Feb 2012 – EAU Paris – Men often finds it difficult to talk with primary health specialists and this is certainly true in the case of BPH.
It is estimated that as many as 24 million European men aged 50 and over experience bothersome urinary symptoms.1,2 Yet, despite experiencing symptoms, men typically wait nearly two… read more.
26 Feb 2012 – EAU Paris, France – What have been some of the EAU highlights to date? And what are some Key messages to share with Irish… read more.
As a man’s waistline grows, so can his experience with sexual dysfunction and frequent urination, say researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Conclusions of the ICD for Life Summit held in Belgrade, Serbia “Implantable devices can save lives and decrease mortality, they are not a luxury”
by Edel O’Connell reporting on the presentation by Professor Eoin O’Brien.
by Edel O’Connell reporting on the presentation by Dr. Stephen Horgan.
by Gary Finnegan – Emerging uses of EMA Approved Drugs – The EMA has given the green light for the first medicine specifically for irritable bowel syndrome (IBS)… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.